Affimed
AFMD
#10508
Rank
NZ$5.15 M
Marketcap
NZ$0.31
Share price
0.00%
Change (1 day)
-92.03%
Change (1 year)

Market capitalization of Affimed (AFMD)

Market cap: NZ$5.15 Million

As of December 2025 Affimed has a market cap of NZ$5.15 Million. This makes Affimed the world's 10508th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Affimed from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$5.15 M-86.26%
2024NZ$37.49 M-74.6%
2023NZ$0.14 B-49.4%
2022NZ$0.29 B-69.87%
2021NZ$0.96 B22.33%
2020NZ$0.79 B155.12%
2019NZ$0.31 B7.17%
2018NZ$0.28 B253.99%
2017NZ$81.76 M-5.39%
2016NZ$86.42 M-75.02%
2015NZ$0.34 B82.31%
2014NZ$0.18 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Affimed was reported to be:

NZ$4.78 Million
by Nasdaq info icon info icon
NZ$5.15 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
NZ$1.42 M-72.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.23 B 4,392.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.38 B 7,420.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$16.07 B 312,041.75%๐Ÿ‡บ๐Ÿ‡ธ USA